Cargando…

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination

INTRODUCTION: To reduce the pertussis disease burden, nowadays several countries recommend acellular pertussis (aP) booster vaccinations for adults. We aimed to evaluate the immunogenicity of a first adult aP booster vaccination at childbearing age. METHODS: In 2014, healthy adults aged 25–29 years...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Lee, Saskia, van Rooijen, Debbie M., de Zeeuw-Brouwer, Mary-Lène, Bogaard, Marjan J. M., van Gageldonk, Pieter G. M., Marinovic, Axel Bonacic, Sanders, Elisabeth A. M., Berbers, Guy A. M., Buisman, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893963/ https://www.ncbi.nlm.nih.gov/pubmed/29670634 http://dx.doi.org/10.3389/fimmu.2018.00681

Ejemplares similares

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
por: Versteegen, Pauline, et al.
Publicado: (2022)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles
por: van der Lee, Saskia, et al.
Publicado: (2018)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
por: Knuutila, Aapo, et al.
Publicado: (2022)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
por: Versteegen, Pauline, et al.
Publicado: (2021)

Pertussis Circulation Has Increased T-Cell Immunity during Childhood More than a Second Acellular Booster Vaccination in Dutch Children 9 Years of Age
por: Schure, Rose-Minke, et al.
Publicado: (2012)

Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands
por: Ohm, Milou, et al.
Publicado: (2020)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
por: Versteegen, Pauline, et al.
Publicado: (2022)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection
por: van der Lee, Saskia, et al.
Publicado: (2017)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
por: Knuutila, Aapo, et al.
Publicado: (2023)

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?
por: Stoof, Susanne P., et al.
Publicado: (2015)

Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination
por: Diks, Annieck M., et al.
Publicado: (2022)

BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial
por: Gillard, Joshua, et al.
Publicado: (2022)

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
por: de Greeff, Sabine C., et al.
Publicado: (2010)

Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults
por: van der Heiden, Marieke, et al.
Publicado: (2017)

Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers
por: Stoof, Susanne P., et al.
Publicado: (2014)

Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis
por: van Twillert, Inonge, et al.
Publicado: (2017)

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections
por: van Twillert, Inonge, et al.
Publicado: (2016)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients
por: Hovingh, Elise S., et al.
Publicado: (2018)

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
por: Tessier, Elise, et al.
Publicado: (2021)

Serum IgA Responses against Pertussis Proteins in Infected and Dutch wP or aP Vaccinated Children: An Additional Role in Pertussis Diagnostics
por: Hendrikx, Lotte H., et al.
Publicado: (2011)

Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8(+) T Cell Immune Response
por: Rieber, Nikolaus, et al.
Publicado: (2011)

Bordetella pertussis Induces Interferon Gamma Production by Natural Killer Cells, Resulting in Chemoattraction by Respiratory Epithelial Cells
por: den Hartog, Gerco, et al.
Publicado: (2020)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy – a prospective, observational cohort study from the United Kingdom
por: Rice, T. F., et al.
Publicado: (2019)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
por: Yount, Kacy S., et al.
Publicado: (2023)

A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy
por: da Silva Antunes, Ricardo, et al.
Publicado: (2021)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_femf8qkf26j4ajfb2493e2jpn2